US Edition
Published • loading... • Updated
Criteriacaixa Sells 560 Million in Shares of Google, Abbvie and Pfizer and Reduces Its Us Portfolio to 289 Million
Summary by negocios.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CriteriaCaixa reduces its U.S. portfolio from 850 to $289 million and sells positions on Google, Abbvie or Pfizer after reviewing its 2030 strategic plan.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
